X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs WYETH LTD - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS WYETH LTD IPCA LABS/
WYETH LTD
 
P/E (TTM) x 30.5 27.7 110.0% View Chart
P/BV x 4.5 5.3 84.1% View Chart
Dividend Yield % 0.1 1.3 8.2%  

Financials

 IPCA LABS   WYETH LTD
EQUITY SHARE DATA
    IPCA LABS
Mar-18
WYETH LTD
Mar-13
IPCA LABS/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6951,044 66.6%   
Low Rs400818 48.9%   
Sales per share (Unadj.) Rs260.2298.6 87.1%  
Earnings per share (Unadj.) Rs19.057.2 33.1%  
Cash flow per share (Unadj.) Rs33.158.4 56.6%  
Dividends per share (Unadj.) Rs1.0017.00 5.9%  
Dividend yield (eoy) %0.21.8 10.0%  
Book value per share (Unadj.) Rs213.0249.5 85.4%  
Shares outstanding (eoy) m126.2022.72 555.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.13.1 67.5%   
Avg P/E ratio x28.916.3 177.5%  
P/CF ratio (eoy) x16.615.9 103.9%  
Price / Book Value ratio x2.63.7 68.9%  
Dividend payout %5.329.7 17.7%   
Avg Mkt Cap Rs m69,12021,157 326.7%   
No. of employees `00013.30.5 2,693.9%   
Total wages/salary Rs m7,359400 1,839.7%   
Avg. sales/employee Rs Th2,477.413,787.4 18.0%   
Avg. wages/employee Rs Th555.2813.0 68.3%   
Avg. net profit/employee Rs Th180.62,643.3 6.8%   
INCOME DATA
Net Sales Rs m32,8366,783 484.1%  
Other income Rs m418353 118.5%   
Total revenues Rs m33,2547,136 466.0%   
Gross profit Rs m4,5051,617 278.5%  
Depreciation Rs m1,77727 6,681.6%   
Interest Rs m2406 4,367.3%   
Profit before tax Rs m2,9051,938 149.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m511632 80.8%   
Profit after tax Rs m2,3941,301 184.1%  
Gross profit margin %13.723.8 57.5%  
Effective tax rate %17.632.6 53.9%   
Net profit margin %7.319.2 38.0%  
BALANCE SHEET DATA
Current assets Rs m19,4556,984 278.6%   
Current liabilities Rs m10,0762,056 490.1%   
Net working cap to sales %28.672.6 39.3%  
Current ratio x1.93.4 56.8%  
Inventory Days Days9899 98.6%  
Debtors Days Days6724 279.7%  
Net fixed assets Rs m20,260244 8,292.9%   
Share capital Rs m252227 111.1%   
"Free" reserves Rs m26,6335,441 489.5%   
Net worth Rs m26,8865,668 474.3%   
Long term debt Rs m2,34025 9,360.4%   
Total assets Rs m41,1737,901 521.1%  
Interest coverage x13.1353.3 3.7%   
Debt to equity ratio x0.10 1,973.3%  
Sales to assets ratio x0.80.9 92.9%   
Return on assets %6.416.5 38.7%  
Return on equity %8.922.9 38.8%  
Return on capital %10.834.0 31.6%  
Exports to sales %47.60.2 21,834.1%   
Imports to sales %14.936.3 40.9%   
Exports (fob) Rs m15,64215 105,689.9%   
Imports (cif) Rs m4,8842,465 198.1%   
Fx inflow Rs m15,64215 102,908.6%   
Fx outflow Rs m4,8842,677 182.4%   
Net fx Rs m10,759-2,662 -404.2%   
CASH FLOW
From Operations Rs m3,411923 369.5%  
From Investments Rs m-1,354317 -427.3%  
From Financial Activity Rs m-1,304-481 271.1%  
Net Cashflow Rs m753759 99.2%  

Share Holding

Indian Promoters % 45.9 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 11.4 11.3 100.9%  
FIIs % 25.3 7.2 351.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 30.4 57.2%  
Shareholders   36,892 21,978 167.9%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA  DR. REDDYS LAB  TORRENT PHARMA  UNICHEM LAB  MERCK  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 336 Points Higher; Banking and Metal Stocks Witness Buying(Closing)

Indian share markets continued to witness buying interest and ended their trading session on a positive note.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

The Best Trading Strategy in the World(Profit Hunter)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

Election Series: Why 'Liquor' is so Important to the Elections(The 5 Minute Wrapup)

Apr 19, 2019

When elections come around, liquor flows like water and everyone gets drunk with power...what does this mean for liquor stocks? Read one to find out from our very own election trading analyst, Vijay Bhambwani.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Apr 26, 2019 03:37 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - SANOFI INDIA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS